Jordan, Christina
Tune Therapeutics | Senior Director, Intellectual Property
In This Section
Christina is Senior Director, Intellectual Property at Tune Therapeutics, where she leads IP portfolio
strategy, development, and management for various programs including epigenome editing. Prior to
joining Tune, she managed global IP portfolio strategy for various programs including cell therapy
and gene editing at Juno Therapeutics/Celgene/Bristol Myers Squibb. Previously, she was in-house
patent counsel at CoMotion, the University of Washington’s Technology Transfer Office, where she
managed all aspects of the life sciences and chemistry patent portfolios for the University of
Washington. Earlier in her career, she practiced law at Lucas & Mercanti LLP in New York City.
She holds a J.D. from Benjamin N. Cardozo School of Law and a B.S. in Microbiology and
Molecular Genetics from UCLA.